Physician profile
Shannon M St Clair
NPI 1003073396
$1,324.93
in general payments reported to CMS, 2019-2025
13 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.95 · 2020: $96.55 · 2021: $264 · 2022: $164 · 2023: $216 · 2024: $363 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $316.60 | 2021-2025 | |
| Amgen INC. | $156.77 | 2019-2024 | Repatha |
| Philips North America LLC | $149.13 | 2024 | (Ck4) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.27 | 2020-2024 | Lifevest |
| Novo Nordisk INC | $125.91 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $121.41 | 2022-2025 | Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.16 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $82.59 | 2020-2021 | |
| Pfizer INC. | $51.00 | 2021-2024 | |
| Cardiva Medical, INC. | $41.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.49 | 2020 | |
| Abiomed | $16.56 | 2023 | Impella |
| Vital Connect, INC | $13.95 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon St Clair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.